Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1127.69
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

James Ronald Nicholls has worked on the following 39 EPO patent applications which have been published in the last five years:

EP11827377

TRANSPOSE BOXES FOR NETWORK INTERCONNECTION

IPC classification:
G06F 15/16
Applicant:
Amazon Technologies Inc
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12763876

INCREMENTAL HIGH RADIX NETWORK SCALING

IPC classification:
H04L 12/66
Applicant:
Amazon Technologies Inc
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP11827352

TRANSPOSE BOX BASED NETWORK SCALING

IPC classification:
H04L 12/931
Applicant:
Amazon Technologies Inc
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12764676

NETWORK TRANSPOSE BOX AND SWITCH OPERATION BASED ON BACKPLANE ETHERNET

IPC classification:
H04L 12/931, H04L 12/933
Applicant:
Amazon Technologies Inc
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP14177863

Humanized IL-6 and IL-6 receptor

IPC classification:
A01K 67/027, C07K 14/54, C07K 14/715
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
EIP Europe LLP
Agent:
James Ronald Nicholls, J A Kemp
Status:
PATENT GRANTED
EP13727964

ALTERNARIA PEPTIDES

IPC classification:
A61K 39/35, A61P 37/08, C07K 14/37
Applicant:
Circassia Limited
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11827482

RIGHTS AND CAPABILITY-INCLUSIVE CONTENT SELECTION AND DELIVERY

IPC classification:
G06F 15/16, H04L 29/06, H04N 21/2343, H04N 21/254, H04N 21/258, H04N 21/45, H04N 21/8355
Applicant:
Amazon Technologies Inc
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13837496

PROTEASE-BASED BIOSENSOR

IPC classification:
C07K 19/00, C12N 9/48, C12N 11/18, C12N 15/57, C12Q 1/37, G01N 33/542
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Agent:
James Ronald Nicholls, J A Kemp
Status:
PATENT GRANTED
EP13851897

DNA METHYLATION BIOMARKERS OF POST-PARTUM DEPRESSION RISK

IPC classification:
C12N 15/11, C12Q 1/68
Applicant:
University of Maryland Baltimore
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14718264

IL-33 ANTAGONISTS AND USES THEREOF

IPC classification:
A61K 38/17, C07K 14/715
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14722437

RODENTS WITH CONDITIONAL ACVR1 MUTANT ALLELES

IPC classification:
A01K 67/027, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11746284

PRODUCTION OF CLOSED LINEAR DNA USING A PALINDROMIC SEQUENCE

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
PATENT GRANTED
EP14722601

STRAND-INVASION BASED DNA AMPLIFICATION METHOD

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15727832

HUMANIZED DIPEPTIDYL PEPTIDASE IV (DPP4) ANIMALS

IPC classification:
A01K 67/027
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15195825

METHOD AND SYSTEM FOR REPRESENTING IMAGE PATCHES

IPC classification:
G06K 9/46, G06K 9/62
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP14814039

ANTIBODIES TO HUMAN RESISTIN

IPC classification:
A61P 9/00, A61P 9/12, A61P 11/00, A61P 11/06, A61P 35/00, C07K 16/18, C12N 15/13
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP11741730

MICE THAT MAKE BINDING PROTEINS COMPRISING VL DOMAINS

IPC classification:
A01K 67/027, C07K 16/00, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
PATENT GRANTED
EP14807179

A BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES

IPC classification:
A61K 38/00, A61K 38/10, C12N 5/00
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14822977

A DNA METHYLATION AND GENOTYPE SPECIFIC BIOMARKER OF SUICIDE ATTEMPT AND/OR SUICIDE IDEATION

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13152077

KIT FOR THE PRODUCTION OF CLOSED LINEAR DNA

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
PATENT GRANTED
EP14826786

A MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME

IPC classification:
C12Q 1/68
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14843309

BIMOLECULAR PROTEASE-BASED BIOSENSOR

IPC classification:
C07K 19/00, C12N 9/48, C12N 11/18, C12N 15/57, C12Q 1/37, G01N 33/542
Agent:
Iain Cheshire Armstrong, HGF Limited
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14781761

HISTIDINE ENGINEERED LIGHT CHAIN ANTIBODIES AND GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THE SAME

IPC classification:
A01K 67/027, C07K 16/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14851059

INSERTION OF IONIZABLE GROUPS IN THE INTERIOR OF PROTEINS AS A STRATEGY FOR ENGINEERING ARTIFICIAL PH-SENSITIVE SWITCH PROTEINS

IPC classification:
C07K 1/00, C07K 2/00, C07K 14/00
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP16163352

MUTANT ENZYMES

IPC classification:
A01K 67/027, C12N 5/10, C12N 9/02, C12N 15/53, C12P 7/16, C12P 7/22
Applicant:
Oxford University Innovation Ltd
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11825294

CARTRIDGE AND AUTOMATIC ANALYSIS DEVICE

IPC classification:
G01N 21/01, G01N 21/03, G01N 35/00, G01N 35/02, G01N 35/04
Agent:
James Ronald Nicholls, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14851841

METABOLICALLY OPTIMIZED CELL CULTURE

IPC classification:
C12N 5/02, C12N 5/16
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14799930

COMPETITIVE LIGAND BINDING ASSAY FOR DETECTING NEUTRALIZING ANTIBODIES

IPC classification:
G01N 33/68
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14800105

DETECTION OF NUCLEIC ACIDS BY STRAND INVASION BASED AMPLIFICATION

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP14835599

NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE

IPC classification:
A01K 67/027, C07K 14/705, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP14803022

NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE

IPC classification:
A01K 67/027, C07K 14/54, C07K 14/705
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP15813960

NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE

IPC classification:
A01K 67/027, C07K 14/705, G01N 33/50
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP15712472

ANTI-EGFRVIII ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, A61K 47/50
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP16192440

HUMANIZED IL-15 ANIMALS

IPC classification:
A01K 67/027, C07K 14/54, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
Request for examination was made
EP15722639

HUMANIZED C5 AND C3 ANIMALS

IPC classification:
A01K 67/027, A61K 49/00, C07K 14/47, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP15726488

HUMAN ANTIBODIES TO MIDDLE EAST RESPIRATORY SYNDROME -CORONAVIRUS SPIKE PROTEIN

IPC classification:
A61K 39/00, A61K 39/215, C07K 16/08
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP15788973

IDENTIFICATION OF NOVEL ANTI-PERSISTER ACTIVITY FOR BORRELIA BURGDORFERI

IPC classification:
A61K 31/00, A61K 38/00, C12Q 1/06, G01N 21/25, G01N 21/64, G01N 33/50
Applicant:
Johns Hopkins University
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED
EP16195596

PRODUCTION OF CLOSED LINEAR DNA

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
APPLICATION PUBLISHED
EP15726183

STRAND-INVASION BASED DNA AMPLIFICATION METHOD

IPC classification:
C12Q 1/68
Agent:
James Ronald Nicholls, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature